These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16952883)
1. Liposome coated stents: a method to deliver drugs to the site of action and improve stent blood-compatibility. Antimisiaris SG; Koromila G; Michanetzis G; Missirlis YF J Liposome Res; 2006; 16(3):303-9. PubMed ID: 16952883 [TBL] [Abstract][Full Text] [Related]
2. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility. Koromila G; Michanetzis GP; Missirlis YF; Antimisiaris SG Biomaterials; 2006 Apr; 27(12):2525-33. PubMed ID: 16410022 [TBL] [Abstract][Full Text] [Related]
3. Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow releasing delivery system of dexamethasone from covered metallic stents. Kallinteri P; Antimisiaris SG; Karnabatidis D; Kalogeropoulou C; Tsota I; Siablis D Biomaterials; 2002 Dec; 23(24):4819-26. PubMed ID: 12361621 [TBL] [Abstract][Full Text] [Related]
4. Liposome-coated metal stents: an in vitro evaluation of controlled-release modality in the ureter. Antimisiaris SG; Siablis D; Liatsikos E; Kalogeropoulou C; Tsota I; Tsotas V; Karnabatidis D; Fatouros DG; Barbalias GA J Endourol; 2000 Nov; 14(9):743-7. PubMed ID: 11110569 [TBL] [Abstract][Full Text] [Related]
5. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents. Mrowietz C; Franke RP; Seyfert UT; Park JW; Jung F Clin Hemorheol Microcirc; 2005; 32(2):89-103. PubMed ID: 15764818 [TBL] [Abstract][Full Text] [Related]
6. Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin. Lambert TL; Dev V; Rechavia E; Forrester JS; Litvack F; Eigler NL Circulation; 1994 Aug; 90(2):1003-11. PubMed ID: 8044913 [TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents. Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460 [TBL] [Abstract][Full Text] [Related]
8. Optimal stent design for drug delivery. Rogers CD Rev Cardiovasc Med; 2004; 5 Suppl 2():S9-S15. PubMed ID: 15184829 [TBL] [Abstract][Full Text] [Related]
9. Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents. Chen W; Habraken TC; Hennink WE; Kok RJ Bioconjug Chem; 2015 Jul; 26(7):1277-88. PubMed ID: 26041505 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-eluting stents: current clinical experience. Grube E; Buellesfeld L Am J Cardiovasc Drugs; 2004; 4(6):355-60. PubMed ID: 15554720 [TBL] [Abstract][Full Text] [Related]
11. Nitric Oxide Releasing Coronary Stent: A New Approach Using Layer-by-Layer Coating and Liposomal Encapsulation. Elnaggar MA; Seo SH; Gobaa S; Lim KS; Bae IH; Jeong MH; Han DK; Joung YK Small; 2016 Nov; 12(43):6012-6023. PubMed ID: 27623489 [TBL] [Abstract][Full Text] [Related]
13. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model. Sharif F; Hynes SO; McCullagh KJ; Ganley S; Greiser U; McHugh P; Crowley J; Barry F; O'Brien T Gene Ther; 2012 Mar; 19(3):321-8. PubMed ID: 21716298 [TBL] [Abstract][Full Text] [Related]
14. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System. Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131 [TBL] [Abstract][Full Text] [Related]
15. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray. Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592 [TBL] [Abstract][Full Text] [Related]
16. Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus. Su LC; Chen YH; Chen MC ACS Appl Mater Interfaces; 2013 Dec; 5(24):12944-53. PubMed ID: 24294944 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents. Grube E; Buellesfeld L Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology. Angst MS; Drover DR Clin Pharmacokinet; 2006; 45(12):1153-76. PubMed ID: 17112293 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries. Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205 [TBL] [Abstract][Full Text] [Related]
20. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. Lincoff AM; Furst JG; Ellis SG; Tuch RJ; Topol EJ J Am Coll Cardiol; 1997 Mar; 29(4):808-16. PubMed ID: 9091528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]